This biotech stock is set to nearly quadruple on the back of its advanced gene therapy products, says Cantor Fitzgerald.
This biotech stock is set to nearly quadruple on the back of its advanced gene therapy products, says Cantor Fitzgerald日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Wall Street drifts as stocks continue to follow the bond market's leadWall Street is drifting in mixed trading, continuing a months-long run where it’s followed the cue of the bond market.
続きを読む »
Wall Street climbs as bond selloff eases, earnings lift moodU.S. stocks rose on Tuesday as a selloff in U.S. Treasuries eased, while upbeat forecasts from Verizon, Coca-Cola and others boosted optimism about corporate America's health in the face of slowing economy and higher inflation.
続きを読む »
Wall Street climbs after profits at big companies top forecastsVerizon jumped 7% after saying it increased its number of broadband subscribers by 20% and earned more than analysts expected during the summer.
続きを読む »